Genetic relatedness among Enterococcus faecalis with transposon-mediated high-level gentamicin resistance in Swedish intensive care units

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 2, 2003, Pages 162-167

  Hällgren, Anita ^a   Saeedi, Baharak ^a   Nilsson, Maud ^a   Monstein, Hans Jürg ^a   Isaksson, Barbro ^a   Hanberger, Håkan ^b   Nillson, Lennart E ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Division of Infectious Diseases   (Sweden)

Author keywords

Enterococcus; High level gentamicin resistance; Pulsed field gel electrophoresis; Transposon

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; CIPROFLOXACIN; GENTAMICIN; MEROPENEM; PLASMID DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLUSTER ANALYSIS; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; GENE CLUSTER; GENOME ANALYSIS; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MOLECULAR CLONING; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; SWEDEN; TRANSPOSON;

CROSS INFECTION; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECALIS; GENTAMICINS; HUMANS; INTENSIVE CARE UNITS; SWEDEN;

EID: 0042529038     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg315     Document Type: Article

References (36)

1. Caballero-Granado, F. J., Cisneros, J. M., Luque, R. et al. (1998). Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el estudio de las Enfermedades Infecciosas. Journal of Clinical Microbiology 36, 520-5.
2. Huycke, M. M., Sahm, D. F. & Gilmore, M. S. (1998). Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerging Infectious Diseases 4, 239-49.
3. Landman, D. & Quale, J. M. (1997). Management of infections due to resistant enterococci: a review of therapeutic options. Journal of Antimicrobial Chemotherapy 40, 161-70.
4. Schouten, M. A., Voss, A. & Hoogkamp-Korstanje, J. A. (1999). Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group. Antimicrobial Agents and Chemotherapy 43, 2542-6.
5. Melhus, A. (1999). [Aminoglycoside-resistant enterococci a new bacterial hazard]. Lakartidningen 96, 1694-5.
6. Hallgren, A., Abednazari, H., Ekdahl, C. et al. (2001). Antimicrobial susceptibility patterns of enterococci in intensive care units in Sweden evaluated by different MIC breakpoint systems. Journal of Antimicrobial Chemotherapy 48, 53-62.
7. Murray, B. E. (1990). The life and times of the Enterococcus. Clinical Microbiology Reviews 3, 46-65.
8. Simjee, S. & Gill, M. J. (1997). Gene transfer, gentamicin resistance and enterococci. Journal of Hospital Infection 36, 249-59.
9. Chow, J. W. (2000). Aminoglycoside resistance in enterococci. Clinical Infectious Diseases 31, 586-9.
10. Hodel-Christian, S. L. & Murray, B. E. (1991). Characterization of the gentamicin resistance transposon Tn5281 from Enterococcus faecalis and comparison to staphylococcal transposons Tn4001 and Tn4031. Antimicrobial Agents and Chemotherapy 35, 1147-52.
11. Kahlmeter, G. (2000). The Swedish Reference Group for Antibiotics (SRGA) and its subcommittee on methodology (SRGA-M) SRGA homepage, version 3. [Online.] http://www.srga.org (4 June 2003, date last accessed).
12. Swenson, J. M., Clark, N. C., Sahm, D. F. et al. (1995). Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci. Journal of Clinical Microbiology 33, 3019-21.
13. Saeedi, B., Hällgren, A., Jonasson, J. et al. (2002). Modified pulsed-field gel electrophoresis protocol for typing of enterococci. Acta Pathologica, Microbiologica et Immunologica Scandinavica 110, 869-74.
14. Tenover, F. C., Arbeit, R. D., Goering, R. V. et al. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 33, 2233-9.
15. Mangan, M. W., McNamara, E. B., Smyth, E. G. et al. (1997). Molecular genetic analysis of high-level gentamicin resistance in Enterococcus hirae. Journal of Antimicrobial Chemotherapy 40, 377-82.
16. De Boever, E. H., Clewell, D. B. & Fraser, C. M. (2000). Enterococcus faecalis conjugative plasmid pAM373: complete nucleotide sequence and genetic analyses of sex pheromone response. Molecular Microbiology 37, 1327-41.
17. el Amin, N. A., Jalal, S. & Wretlind, B. (1999). Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faecium. Antimicrobial Agents and Chemotherapy 43, 947-9.
18. Kobayashi, N., Alam, M., Nishimoto, Y. et al. (2001). Distribution of aminoglycoside resistance genes in recent clinical isolates of Enterococcus faecalis, Enterococcus, faecium and Enterococcus avium. Epidemiology and Infection 126, 197-204.
19. Simjee, S., Manzoor, S. E., Fraise, A. P. et al. (2000). Nature of transposon-mediated high-level gentamicin resistance in Enterococcus faecalis isolated in the United Kingdom. Journal of Antimicrobial Chemotherapy 45, 565-75.
20. Dyke, K. G., Aubert, S. & el Solh, N. (1992). Multiple copies of IS256 in staphylococci. Plasmid 28, 235-46.
21. Silverman, J., Thal, L. A., Perri, M. B. et al. (1998). Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci. Journal of Clinical Microbiology 36, 830-2.
22. Aarestrup, F. M., Agerso, Y., Gerner-Smidt, P. et al. (2000). Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark. Diagnostic Microbiology and Infectious Disease 37, 127-37.
23. Coque, T. M., Arduino, R. C. & Murray, B. E. (1995). High-level resistance to aminoglycosides: comparison of community and nosocomial fecal isolates of enterococci. Clinical Infectious Diseases 20, 1048-51.
24. Dicuonzo, G., Gherardi, G., Lorino, G. et al. (2001). Antibiotic resistance and genotypic characterization by PFGE of clinical and environmental isolates of enterococci. FEMS Microbiology Letters 201, 205-11.
25. Bonten, M. J., Austin, D. J. & Lipsitch, M. (2001). Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control. Clinical Infectious Diseases 33, 1739-46.
26. Austin, D. J., Bonten, M. J., Weinstein, R. A. et al. (1999). Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proceedings of the National Academy of Sciences, USA 96, 6908-13.
27. Pittet, D., Hugonnet, S., Harbarth, S. et al. (2000). Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 356, 1307-12.
28. Bonten, M. J., Hayden, M. K., Nathan, C. et al. (1996). Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 348, 1615-9.
29. Mellmann, A., Orth, D., Dierich, M. P. et al. (2000). Nosocomial cross transmission as a primary cause of vancomycin-resistant enterococci in Austria. Journal of Hospital Infection 44, 281-7.
30. Hayden, M. K. (2000). Insights into the epidemiology and control of infection with vancomycin-resistant enterococci. Clinical Infectious Diseases 31, 1058-65.
31. Kanematsu, E., Deguchi, T., Yasuda, M. et al. (1998). Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis. Antimicrobial Agents and Chemotherapy 42, 433-5.
32. Ferretti, J. J., Gilmore, K. S. & Courvalin, P. (1986). Nucleotide sequence analysis of the gene specifying the bifunctional 6′-aminoglycoside acetyltransferase 2″-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities. Journal of Bacteriology 167, 631-8.
33. Casetta, A., Hoi, A. B., de Cespedes, G. et al. (1998). Diversity of structures carrying the high-level gentamicin resistance gene (aac6-aph2) in Enterococcus faecalis strains isolated in France. Antimicrobial Agents and Chemotherapy 42, 2889-92.
34. del Campo, R., Tenorio, C., Rubio, C. et al. (2000). Aminoglycoside-modifying enzymes in high-level streptomycin and gentamicin resistant Enterococcus spp. in Spain. International Journal of Antimicrobial Agents 15, 221-6.
35. Eliopoulos, G. M., Wennersten, C., Zighelboim-Daum, S. et al. (1988). High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium. Antimicrobial Agents and Chemotherapy 32, 1528-32.
36. Horodniceanu, T., Bougueleret, L., El-Solh, N. et al. (1979). High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes. Antimicrobial Agents and Chemotherapy 16, 686-9.